Lake Street Advisors Group LLC lessened its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 0.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,407 shares of the financial services provider’s stock after selling 67 shares during the period. Lake Street Advisors Group LLC’s holdings in CME Group were worth $2,439,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its holdings in shares of CME Group by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock worth $7,044,821,000 after acquiring an additional 215,044 shares during the period. Capital International Investors grew its stake in shares of CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. Capital World Investors increased its position in shares of CME Group by 8.7% during the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after purchasing an additional 1,172,575 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in shares of CME Group by 2.9% in the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock worth $1,462,678,000 after purchasing an additional 189,842 shares during the period. Finally, Parnassus Investments LLC lifted its stake in shares of CME Group by 0.4% in the 4th quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock worth $1,193,551,000 after purchasing an additional 23,583 shares during the period. Institutional investors own 87.75% of the company’s stock.
Insider Activity
In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.
Wall Street Analyst Weigh In
Get Our Latest Analysis on CME Group
CME Group Stock Up 0.5 %
NASDAQ CME opened at $220.50 on Friday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a market cap of $79.39 billion, a PE ratio of 25.09, a P/E/G ratio of 6.51 and a beta of 0.52. The stock’s 50 day moving average is $203.51 and its 200 day moving average is $207.61.
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.30 earnings per share. Research analysts predict that CME Group Inc. will post 9.89 EPS for the current fiscal year.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.09%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- Upcoming IPO Stock Lockup Period, Explained
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- What Are the FAANG Stocks and Are They Good Investments?
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Top Stocks Investing in 5G Technology
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.